Current possibilities of using silver proteinate in the treatment of inflammatory diseases of the nose and paranasal sinuses

The article evaluates the possibility of using silver proteinate to treat acute inflammatory diseases of the nasal cavity and paranasal sinus mucosa, as well as their complications. Acute rhinitis and rhinosinusitis are among the most common upper respiratory diseases. Viral pathogens are the main agents that trigger the pathological process. At the same time, the bacterial superinfection in some cases may develop due to viral infection, which promotes further development of lingering clinical symptoms up to a complicated course of the disease. The course of rhinosinusitis with underlying COVID-19 infection can be complicated by fungal superinfection and postnasal drip. For these reasons, topical drugs that could be used in the early stages of these conditions should have a number of properties, such as activity against most respiratory viruses and aetiologically significant bacterial pathogens; lack of opportunity to evolute and implement rapid resistance mechanisms in microorganisms; additive effects with other antibacterial drugs; acceleration of regeneration of the nasal cavity and paranasal sinus mucosa with underlying infectious alteration; vasoconstrictive and anti-inflammatory action, without causing an addictive effect, which enables repeated use of the drug in chronic diseases, as well as the absence of local and systemic toxic effects. Sialor (silver proteinate) has all the specified characteristics that were proved in various studies, and consistently demonstrated high clinical efficacy for many years.

1. Ali M.Y. Histology of the human nasopharyngeal mucosa. J Anat. 1965;99(3):657–672. Available at: https://pubmed.ncbi.nlm.nih.gov/5857093.

2. Radtsig E.Yu., Bogomilsky M.R., Laberko E.L., Ermilova N.V. The relationship of age-related features of the structure of the nasal mucosa and methods of administration of drugs for the treatment of acute infectious rhinitis in children and adolescents. Pediatriya – Zhurnal im G.N. Speranskogo. (In Russ.) Available at: https://pediatriajournal.ru/archive?show=324&section=3470.

3. Piskunov G.Z., Piskunov S.Z. Clinical rhinology. Moscow: MIA; 2017. 750 p. (In Russ.)

4. Fokkens W.J., Lund V.J., Mullol J., Bachert C., Alobid I., Baroody F. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;23:1–298. Available at: https://pubmed.ncbi.nlm.nih.gov/22764607.

5. Wang D.Y., Wardani R.S., Singh K., Thanaviratananich S., Vicente G., Xu G. et al. A survey on the management of acute rhinosinusitis among Asian physicians. Rhinology. 2011;49(3):264–271. https://doi.org/10.4193/rhino10.169.

6. Anand V.K. Epidemiology and Economic Impact of Rhinosinusitis. Ann Otol Rhinol Laryngol Suppl. 2004;193:3–5. https://doi.org/10.1177/00034894041130s502.

7. Ovchinnikov A.Yu., Miroshnichenko N.A., Shagramanyan G.B., Ryabini V.A. Topical treatment of acute rhinosinusitis in outpatient departments. RMJ. 2016;(21):1407–1410. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Roly_mestnoy_terapii_v_lechenii_bolynyh_s_ostrym_rinosinusitom_v_ambulatornyh_usloviyah.

8. Turner R.B. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol. 1997;78(6):531–539. https://doi.org/10.1016/S1081-1206(10)63213-9.

9. Bachert C., Hörmann K., Mösges R., Rasp G., Riechelmann H., Müller R. et al. An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy. 2003;58(3):176–191. https://doi.org/10.1034/j.1398-9995.2003.02172.x.

10. Oskarsson J.P., Halldórsson S. An evaluation of diagnosis and treatment of acute sinusitis at three health care centers. Laeknabladid. 2010;96(9):531–535. https://doi.org/10.17992/lbl.2010.09.313.

11. Hoffmans R., Wagemakers A., van Drunen C., Hellings P., Fokkens W. Acute and chronic rhinosinusitis and allergic rhinitis in relation to comorbidity, ethnicity and environment. PLoS ONE. 2018;13(2):e0192330. https://doi.org/10.1371/journal.pone.0192330.

12. Smith S.S., Ference E.H., Evans C.T., Tan B.K., Kern R.C., Chandra R.K. The prevalence of bacterial infection in acute rhinosinusitis: a Systematic review and meta-analysis. Laryngoscope. 2015;125(1):57–69. https://doi.org/10.1002/lary.24709.

13. Heikkinen T., Järvinen A. The common cold. Lancet. 2003;361(9351):51–59. https://doi.org/10.1016/S0140-6736(03)12162-9.

14. Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z. et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020;382(12):1177–1179. https://doi.org/10.1056/nejmc2001737.

15. Alekseenko S., Karpischenko S., Barashkova S. Comparative Analysis of Mucociliary Clearance and Mucosal Morphology Using High-Speed Videomicroscopy in Children With Acute and Chronic Rhinosinusitis. Am J Rhinol Allergy. 2021;35(5):656–663. https://doi.org/10.1177/1945892420988804.

16. Benninger M.S., Senior B.A. The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg. 1997;123(11):1175–1179. https://doi.org/10.1001/archotol.1997.01900110025004.

17. Alharbi S.A., Wainwright M., Alahmadi T.A., Salleeh H.B., Faden A.A., Chinnathambi A. What if Fleming had not discovered penicillin? Saudi J Biol Sci. 2014;21(4):289–293. https://doi.org/10.1016/j.sjbs.2013.12.007.

18. Barillo D.J., Marx D.E. Silver in medicine. A brief history BC 335 to present. Burns. 2014;40(1):3–8. https://doi.org/10.1016/j.burns.2014.09.009.

19. Ebrahiminezhad A., Raee M. J., Manafi Z., Sotoodeh Jahromi A., Ghasemi Y. Ancient and Novel Forms of Silver in Medicine and Biomedicine. J Adv Med Sci Appl Technol. 2016;2(1):122–128. https://doi.org/10.18869/nrip.jamsat.2.1.122.

20. Alexander J.W. History of the Medical Use of Silver. Surg Infect (Larchmt). 2009;10(1):289–292. https://doi.org/10.1089/sur.2008.9941.

21. Eremeeva K.V., Petrova E.I., Svistushkin V.M. Silver proteinate in ENT practice: is the new a well-forgotten old? RMJ. 2015;(23):1381–1383. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Proteinat_serebra_v_LOR-praktike_novoe__eto_horoshozabytoe_staroe.

22. Kryukov A.I., Tsarapkin G.Yu., Tovmasyan A.S., Gorovaya E.V., Vershinina E.A. Administration of topical antimicrobial agents in the complex treatment of upper respiratory tract pathology. RMJ. 2020;(5):32–42. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Primenenie_mestnyh_antimikrobnyh_sredstv_v_kompleksnom_lechenii_patologii_verhnih_dyhatelynyh_putey.

23. Jung W.K., Koo H.C., Kim K.W., Shin S., Kim S.H., Park Y.H. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol. 2008;74(7):2171–2178. https://doi.org/10.1128/aem.02001-07.

24. Morones-Ramirez J.R., Winkler J.A., Spina C.S., Collins J.J. Silver enhances antibiotic activity against gram-negative bacteria. Sci Transl Med. 2013;5(190):190ra81. https://doi.org/10.1126/scitranslmed.3006276.

25. Tran P.L., Luth K., Wang J., Ray C., de Souza A., Mehta D. et al. Efficacy of a silver colloidal gel against selected oral bacteria in vitro. F1000Res. 2019;8:267. https://doi.org/10.12688/f1000research.17707.1.

26. Fong J., Wood F., Fowler B. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits. Burns. 2005;31(5):562–567. https://doi.org/10.1016/j.burns.2004.12.009.

27. Kanner E.V., Usenko D.V., Maksimov M.L., Gorelova E.A. Modern approaches to the treatment of acute nasopharyngitis in children. RMJ. 2014;(21):1541. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Sovremennye_podhody_k_terapii_ostrogo_rinofaringita_u_detey.

28. Gurov A.V., Yushkina M.A. Possibilities of local therapy of purulentinflammatory diseases of the nasal cavity. RMJ. 2017;(6):410–413. (In Russ.) Available at: https://www.rusmedreview.com/upload/iblock/110/RMJ_06_2017_LOR.pdf#page=20.

29. Derbeneva M.L., Guseva A.L. Silver-based drugs in the treatment of inflammatory diseases of the nose. Meditsinskiy Sovet. 2015;(15):20–23. (In Russ.) Available at: https://www.med-sovet.pro/jour/article/view/377.

30. El-Kholy N.A., El-Fattah A.M.A., Khafagy Y.W. Invasive Fungal Sinusitis in Post COVID-19 Patients: A New Clinical Entity. Laryngoscope. 2021;131(12):2652–2658. https://doi.org/10.1002/lary.29632.

31. Ashour M.M., Abdelaziz T.T., Ashour D.M., Askoura A., Saleh M.I., Mahmoud M.S. Imaging spectrum of acute invasive fungal rhino-orbitalcerebral sinusitis in COVID-19 patients: A case series and a review of literature. J Neuroradiol. 2021;48(5):319–324. https://doi.org/10.1016/j.neurad.2021.05.007.

32. Manchanda S., Semalti K., Bhalla A.S., Thakar A., Sikka K., Verma H. Revisiting rhino-orbito-cerebral acute invasive fungal sinusitis in the era of COVID-19: pictorial review. Emerg Radiol. 2021;28(6):1063–1072. https://doi.org/10.1007/s10140-021-01980-9.

33. Guy K., Lelegren M., Shomaker K., Han J., Lam K. Management of complicated acute sinusitis in the setting of concurrent COVID-19. Am J Otolaryngol. 2022;43(5):103603. https://doi.org/10.1016/j.amjoto.2022.103603.

34. Lansdown A.B. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol. 2006;33:17–34. https://doi.org/10.1159/000093928.